Skip to main content

Advertisement

SpringerLink
Log in

Hepatitis B virus reactivation associated with ruxolitinib

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Harrison C, Kiladjian JJ, Al-Ali HK et al (2012) JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. N Engl J Med 366:787–798

    Article  CAS  PubMed  Google Scholar 

  2. Verstovsek S, Mesa RA, Gotlib J et al (2012) A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. N Engl J Med 366:799–807

    Article  CAS  PubMed  Google Scholar 

  3. O’Shea JJ, Holland SM, Staudt LM (2013) JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med 368:161–170

    Article  PubMed  Google Scholar 

  4. Kontzias A, Kotlyar A, Laurence A et al (2012) Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease. Curr Opin Pharmacol 12:464–470

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Tefferi A (2012) JAK inhibitors for myeloproliferative neoplasms: clarifying facts from myths. Blood 119:2721–2730

    Article  CAS  PubMed  Google Scholar 

  6. Wathes R, Moule S, Milojkovic D (2013) Progressive multifocal leukoencephalopathy associated with ruxolitinib. N Engl J Med 369:197–198

    Article  CAS  PubMed  Google Scholar 

  7. Goldberg RA, Reichel E, Oshry LJ (2013) Bilateral toxoplasmosis retinitis associated with ruxolitinib. N Engl J Med 369:681–683

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Department of Medicine, Chang Gung Memorial Hospital-Chiayi, Chiayi, Taiwan, Republic of China

    Chien-Heng Shen

  2. Division of Hematology Oncology, Department of Medicine, Chang Gung Memorial Hospital-Chiayi, Chiayi, Taiwan, Republic of China

    Cih-En Hwang, Yi-Yang Chen & Chih-Cheng Chen

  3. Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan, Republic of China

    Chien-Heng Shen & Chih-Cheng Chen

Authors
  1. Chien-Heng Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cih-En Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yi-Yang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chih-Cheng Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chih-Cheng Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shen, CH., Hwang, CE., Chen, YY. et al. Hepatitis B virus reactivation associated with ruxolitinib. Ann Hematol 93, 1075–1076 (2014). https://doi.org/10.1007/s00277-013-1936-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-013-1936-5

Keywords

Search

Navigation